Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 467

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT05415020
RLB — Determining the Utility of a Behavioral Intervention in Chronic M…
RLB — Determining the Utility of … Migraine Non applicable RECRUITING En attente / non publié Mayo Clinic United States · Mayo Clinic, Phoenix, United States 2022-06-29 → 2027-07-31 Ouvrir
NCT07103694
i-NEED: NEw migrainE Drugs Database
anti-CGRP monoclonal antibodies Migraine À vérifier RECRUITING En attente / non publié IRCCS San Raffaele Roma Italy · IRCCS San Raffaele, Rome, Italy | Istituto Au… 2022-03-24 → 2026-12-31 Ouvrir
NCT06409845
TACHIS — Effectiveness and Tolerability of Eptinezumab
Eptinezumab 100 or 300 mg ev Migraine À vérifier COMPLETED En attente / non publié University of Florence Italy · SISC, Florence, Italy 2024-03-26 → 2026-04-01 Ouvrir
NCT07644299
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Pr…
Self-Hypnosis Training for Migrai… Migraine Non applicable NOT_YET_RECRUITING En attente / non publié Ciusss de L'Est de l'Île de Montr… Canada · Centre de recherche de l'Hôpital Maisonneuve… 2026-06-01 → 2027-09-30 Ouvrir
NCT05814497
SCP — Supraspinal Processing of Sensory Aspects of Pain
SCP — Supraspinal Processing of S… Migraine Non applicable RECRUITING En attente / non publié Children's Hospital Medical Cente… United States · Cincinnati Children's Hospital, Cinci… 2023-05-01 → 2027-06-30 Ouvrir
NCT05164172
REJOIN — A Study With Eptinezumab in Children and Adolescents (6 to 17 …
Eptinezumab Migraine Phase 3 RECRUITING En attente / non publié H. Lundbeck A/S United States, Argentina, Canada, Italy, Mexico, Pola… 2021-12-01 → 2028-04-30 Ouvrir
NCT06323928
PROCEED — A Dose-finding Trial With Lu-AG09222 in Adults With Migraine …
Lu AG09222 Migraine Phase 2 COMPLETED En attente / non publié H. Lundbeck A/S United States, Bulgaria, Czechia, Denmark, France, Ge… 2024-04-01 → 2026-03-16 Ouvrir
NCT05216263
ATO-BOTOX — Study of Oral Atogepant When Added to OnabotulinumtoxinA (B…
Atogepant Migraine Phase 3 COMPLETED En attente / non publié AbbVie United States · Albany Medical College /ID# 242757, A… 2022-03-22 → 2025-05-02 Ouvrir
NCT06170281
SMARTMig — Sequential, Multiple Assignment, Double Randomized Preferenc…
SMARTMig — Sequential, Multiple A… Migraine Non applicable NOT_YET_RECRUITING En attente / non publié Mayo Clinic United States · Mayo Clinic, Phoenix, United States 2026-12 → 2028-12-01 Ouvrir
NCT04715685
Mind Body Balance for Pediatric Migraine
Mind Body Balance for Pediatric M… Migraine Non applicable RECRUITING En attente / non publié Children's Hospital Medical Cente… United States · Cincinnati Children's Hospital Medica… 2021-03-09 → 2026-11-30 Ouvrir
NCT07067112
SIIM-reg — Suppressive Functions of Regulatory T Cells in Migraine
Blood sampling, questionnaire and… Migraine Non applicable NOT_YET_RECRUITING En attente / non publié University Hospital, Clermont-Fer… France · CHU Clermont-Ferrand, Clermont-Ferrand, Fran… 2026-07-01 → 2027-11-30 Ouvrir
NCT02090998
Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transfo…
SPG Block with 5% Lidocaine gel Migraine Phase 4 TERMINATED En attente / non publié Rutgers, The State University of … United States · Rutgers, Robert Wood Johnson Medical … 2014-05 → 2020-03-16 Ouvrir
NCT07018713
MINT-C — A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® In…
Xeomin Migraine Phase 3 RECRUITING En attente / non publié Merz Therapeutics GmbH United States, Austria, Canada, Czechia, Denmark, Fra… 2025-08-21 → 2028-03 Ouvrir
NCT05748483
ATO-TOPIRAMATE — Comparative Study of Oral Atogepant Versus Oral Topira…
Atogepant Migraine Phase 3 COMPLETED En attente / non publié AbbVie Austria, Belgium, Canada, Czechia, France, Germany, H… 2023-10-07 → 2026-06-02 Ouvrir
NCT07690215
PRACTICE — Study to Assess Effectiveness of Oral Atogepant in Adult Par…
PRACTICE — Study to Assess Effect… Migraine À vérifier NOT_YET_RECRUITING En attente / non publié AbbVie Non communiqué 2026-09-01 → 2028-03 Ouvrir
NCT07691164
CEREB — Evolution of the Cognitive Profile and Quality of Life of Adult…
CEREB — Evolution of the Cognitiv… Migraine Non applicable NOT_YET_RECRUITING En attente / non publié University Hospital, Strasbourg, … France · Hopitaux Universitaires de Strasbourg, Stras… 2026-10-01 → 2029-09-30 Ouvrir
NCT05858801
SalviaBio — First Evaluation of a Craniofacial Nerve Stimulation System…
PRIMUS Migraine Non applicable ACTIVE_NOT_RECRUITING En attente / non publié Salvia BioElectronics Belgium · AZ Delta, Roeselare, Belgium 2023-05-09 → 2027-12-31 Ouvrir
NCT06810505
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change i…
Atogepant Migraine Phase 3 RECRUITING En attente / non publié AbbVie United States, Canada, Denmark, Hungary, Italy, Japan… 2025-02-13 → 2031-03 Ouvrir
NCT07500558
Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Ve…
Standarad PRF Migraine Non applicable RECRUITING En attente / non publié Minia University Egypt · Minia university raouf, Minya, Egypt | Minia … 2026-03-31 → 2027-04-02 Ouvrir
NCT06735833
MMA Embolization for Refractory Chronic Migraine
Middle Meningeal Artery embolizat… Migraine Non applicable RECRUITING En attente / non publié The Affiliated Hospital Of Guizho… United States · Barrow Neurological Institute at St. … 2025-04-23 → 2029-07-31 Ouvrir
NCT04965675
PROSPECT-2 — A Study With Eptinezumab in Adolescents (12-17 Years) With…
Eptinezumab Migraine Phase 3 RECRUITING En attente / non publié H. Lundbeck A/S United States, Argentina, Canada, Italy, Mexico, Pola… 2021-06-30 → 2026-10-31 Ouvrir
NCT06158737
A Clinical Trial Evaluated the Safety and Tolerability, Pharmacokinetic…
JS010 injection Migraine Phase 1 COMPLETED En attente / non publié Shanghai Junshi Bioscience Co., L… China · Peking University Third Hospital, Beijing, Ch… 2023-05-10 → 2024-06-23 Ouvrir
NCT07698249
Headache Diary for Migraine Patients
Headache Diary for Migraine Patie… Migraine Non applicable ENROLLING_BY_INVITATION En attente / non publié Hackensack Meridian Health United States · Hackensack Meridian Health - JFK Medi… 2025-01-14 → 2029-08-01 Ouvrir
NCT05576467
TEAM-M — Treatment for Migraine and Mood
TEAM-M — Treatment for Migraine a… Migraine Non applicable ACTIVE_NOT_RECRUITING En attente / non publié Amanda Shallcross United States · Albert Einstein College of Medicine, … 2024-03-17 → 2026-10-20 Ouvrir
NCT06485336
Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicS…
Atorvastatin 40mg Migraine Phase 2 RECRUITING En attente / non publié St. Olavs Hospital Norway · Haukeland University Hospital, Bergen, Norwa… 2024-05-01 → 2029-02-28 Ouvrir